title: Electroconvulsive therapy using rocuronium and sugammadex in patient with neuroleptic malignant syndrome.
authors.forename: N
authors.initials: N
authors.lastname: Saeki
authors.forename: R
authors.initials: R
authors.lastname: Kwon
authors.forename: T
authors.initials: T
authors.lastname: Migita
authors.forename: H
authors.initials: H
authors.lastname: Fukuda
authors.forename: H
authors.initials: H
authors.lastname: Hamada
authors.forename: M
authors.initials: M
authors.lastname: Kawamoto
mesh_terms: D000732:Androstanols / Q000009:adverse effects / Q000037:antagonists & inhibitors; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D003919:Diabetes Insipidus / Q000139:chemically induced; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000628:therapy*; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D000077123:Rocuronium; D013390:Succinylcholine / Q000009:adverse effects; D000077122:Sugammadex; D047408:gamma-Cyclodextrins
chemical_list: D000732:Androstanols; D009467:Neuromuscular Depolarizing Agents; D047408:gamma-Cyclodextrins; D016651:Lithium Carbonate; D000077122:Sugammadex; D013390:Succinylcholine; D000077123:Rocuronium